Brief: Akari Therapeutics PLC Announces ADS Ratio Change
15/08/2023 13:04
Aug 15 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS, PLC ANNOUNCES ADS RATIO CHANGE
* AKARI THERAPEUTICS PLC - RATIO CHANGE IS EXPECTED TO BE
EFFECTIVE ON AUGUST 17, 2023
Source text for Eikon: ID:nGNEb2vpXJ
Further company coverage: AKTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics